Medizinische Universität Graz - Research portal
Selected Publication:
Klein, W; Eber, B; Gasser, R; Stoschitzky, K; Schumacher, M; Fruhwald, FM; Zweiker, R.
Current aspects of ACE inhibitor therapy from the cardiologic viewpoint
Wien Med Wochenschr. 1996; 146(11):221-224
PubMed
- Co-authors Med Uni Graz
- Fruhwald Friedrich
- Gasser Robert
- Stoschitzky Kurt
- Zweiker Robert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- From a cardiologist's view there are several established indications for the use of ACE-inhibitors like hypertension, heart failure and acute myocardial infarction. In other forms of coronary artery disease like stable and unstable angina and prevention of arteriosclerotic complications. ACE-inhibitors are under discussion. As antihypertensives ACE-inhibitors are about equally effective as calcium blockers, betablockers and diuretics without the negative effects on lipid metabolism and insulin sensitivity. Vascular and cardial remodelling are prevented with ACE-inhibitors at least to a certain degree. In heart failure ACE-inhibitors reduce morbidity and mortality, if left ventricular ejection fraction is reduced. In acute myocardial infarction ACE-inhibitors are indicated in overt heart failure, depressed left ventricular function and high-risk-patients. In silent ischaemia and secondary prevention ACE-inhibitors are under discussion.
- Find related publications in this database (using NLM MeSH Indexing)
- Angiotensin-Converting Enzyme Inhibitors - adverse effects
- Heart Failure - drug therapy
- Hemodynamics - drug effects
- Humans - drug effects
- Hypertension - drug therapy
- Myocardial Infarction - drug therapy
- Survival Rate - drug therapy
- Treatment Outcome - drug therapy
- Ventricular Function, Left - drug effects